Ingalls & Snyder LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,760
| Closed | -$314K | – | 431 |
|
|
2022
Q4 | $314K | Buy |
+2,760
| New | +$314K | 0.02% | 324 |
|
|
2022
Q3 | – | Sell |
-2,864
| Closed | -$228K | – | 434 |
|
|
2022
Q2 | $228K | Hold |
2,864
| – | – | 0.01% | 367 |
|
|
2022
Q1 | $301K | Buy |
2,864
+19
| +0.7% | +$2K | 0.01% | 352 |
|
|
2021
Q4 | $307K | Sell |
2,845
-4
| -0.1% | -$432 | 0.01% | 355 |
|
|
2021
Q3 | $312K | Sell |
2,849
-140
| -5% | -$15.3K | 0.01% | 358 |
|
|
2021
Q2 | $280K | Sell |
2,989
-71
| -2% | -$6.65K | 0.01% | 379 |
|
|
2021
Q1 | $282K | Buy |
3,060
+158
| +5% | +$14.6K | 0.01% | 360 |
|
|
2020
Q4 | $212K | Buy |
2,902
+175
| +6% | +$12.8K | 0.01% | 386 |
|
|
2020
Q3 | $212K | Buy |
+2,727
| New | +$212K | 0.01% | 333 |
|